𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activation of nuclear factor kappa B (NF-κB) assayed by laser scanning cytometry (LSC)

✍ Scribed by Deptala, Andrzej (author);Bedner, Elzbieta (author);Gorczyca, Wojciech (author);Darzynkiewicz, Zbigniew (author)

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
226 KB
Volume
33
Category
Article
ISSN
0196-4763

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activation of nuclear factor kappa B (NF
Activation of nuclear factor kappa B (NF-κB) assayed by laser scanning cytometry (LSC)
✍ Deptala, Andrzej (author);Bedner, Elzbieta (author);Gorczyca, Wojciech (author); 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Nuclear factor kappa B (NF-B)/rel is the family of ubiquitous transcriptional activators involved in regulation of diverse immune and inflammatory responses. It also plays a role in control of cell growth and apoptosis. In its inactive form NF-B remains in the cytoplasm sequestered through interacti

Inhibition of nuclear factor kappa B (NF
Inhibition of nuclear factor kappa B (NFκB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
✍ Giulio Taglialatela; Robert Robinson; J. Regino Perez-Polo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

The mechanism(s) underlying nerve growth factor (NGF)-mediated rescue of neurons from apoptosis is poorly understood, although it is well established that the high-affinity NGF receptor (TrkA) plays a pivotal role in mediating NGF effects. The report that the low-affinity NGF receptor (p75 NGFR ) ca

The antirheumatic drug leflunomide inhib
The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-κB ligand–stimulated induction of nuclear factor of activated T cells c1
✍ Makoto Urushibara; Hiroshi Takayanagi; Takako Koga; Sunhwa Kim; Miho Isobe; Yasu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB 👁 2 views

## Abstract ## Objective Suppression of bone destruction is required as part of an effective therapeutic strategy for autoimmune arthritis. Although numerous antirheumatic drugs are in clinical use, little is known about whether they inhibit bone destruction by acting on activated T cells or other